PPARγ is generally believed to be a tumor suppressor as numerous in vitro studies show that PPARγ agonists (for instance thiazolidinediones) are able to inhibit tumor cell growth and/or induce differentiation in many different cancers [21, 67]. The gene discussed is PPARG; the disease is cancer.